Acquisition-Related Amortization and Remeasurement - Additional Information (Details) - USD ($) $ in Millions	Apr. 07, 2021	Feb. 02, 2021
License Agreement [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Contingent Payment Upon Reaching FDA Milestone	$ 4.0
Amount Received for the year	$ 0.5
Intellectual Property Rights [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Consideration transferred		$ 1.0
Consideration transferred		$ 9.0
Maximum [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Royalty percentage on net sales		4.00%
Maximum [Member] | Intellectual Property Rights [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Consideration transferred		$ 10.0
Minimum [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Royalty percentage on net sales		2.00%